drugset / Trial / NCT00356395

Safety and Effects of Ramipril Combined With Candesartan

NCT00356395

Phase 4 Completed 40 enrolled Gachon University Gil Medical Center
RandomizedCrossoverDouble-blindTreatment

Summary

we hypothesized that combination therapy has additive beneficial effects to improve endothelial dysfunction and adipocytokine profiles in patients with hypertension.

Timeline

Start
2003-08
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan Unknown 16 mg
Subject Ramipril Small molecule 10 mg

Indications